Delivering a new standard for
clinical trial imaging data and workflow
With thousands of imaging clinical trials relying on the platform each day,
Yunu is serving life science companies and cancer centers to ignite collaboration and accelerate innovation.
Access & Diversity
In oncology, 90% of clinical trials require tumor measurements, but access and diversity issues arise because most trials occur at a few sites. Only 3% of patients from where 80% of the population receives care enroll in trials. To address this, a platform that allows data sharing and collaboration across sites and at the community level is essential."
Dr. Gordon Harris | Co-Dir. of the Tumor Imaging Metrics Core at Dana Farber / Harvard Cancer Center & Co-founder & CSO, Yunu
Collaboration
"We actually end up collaborating a great deal with the radiology department. And once we started looking at the data itself, we realized that more than 50% of all of our findings had some level of issues."
Dr. Arcadia Cruz | Associate Administrative Director UC San Diego Moores Cancer Center
Customer Support
The Yunu team has been incredibly supportive of every issue that we have. We have a really good team. So, it's almost like having an entire partnership that has changed our outcomes. We are meeting the endpoints for our protocols with specificity, efficiency, and reproducibility.
Dr. Arcadia Cruz | Associate Administrative Director UC San Diego Moores Cancer Center
Unlock imaging data. Unify multi-site trials.
By theNumbers
Article | Clinical Trial Vanguard
Urgent Warning: Dangers and Costsof Clinical Trial Imaging Errors
Why choose Yunu?
Why choose Yunu?
Through the power of multi-organization workflows and true cloud-based collaboration, Yunu makes it possible to connect study teams, core labs, sponsors, CROs, and off-site clinical resources so that scaling your clinical trials operation does not distract from busy clinical routines.
4,200+
Clinical trials that extend to
over 8000 clinical sites
2,600+
Registered Yunu solution users
across all types of study staff
400+
Life sciences companies are lead sponsors of trials on Yunu
